Bank of Jackson Hole Trust Takes Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bank of Jackson Hole Trust purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 475 shares of the exchange traded fund’s stock, valued at approximately $43,000.

A number of other hedge funds have also made changes to their positions in the company. Hartline Investment Corp increased its position in shares of SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after buying an additional 106 shares in the last quarter. Signature Estate & Investment Advisors LLC increased its position in shares of SPDR S&P Biotech ETF by 5.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock valued at $231,000 after buying an additional 125 shares in the last quarter. Graypoint LLC increased its position in shares of SPDR S&P Biotech ETF by 5.6% in the third quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock valued at $271,000 after buying an additional 146 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of SPDR S&P Biotech ETF by 0.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock valued at $2,373,000 after buying an additional 148 shares in the last quarter. Finally, Key Financial Inc increased its position in shares of SPDR S&P Biotech ETF by 24.6% in the third quarter. Key Financial Inc now owns 766 shares of the exchange traded fund’s stock valued at $76,000 after buying an additional 151 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 0.2 %

Shares of XBI stock opened at $92.72 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The stock has a market cap of $7.07 billion, a P/E ratio of 11.47 and a beta of 1.11. The business has a fifty day simple moving average of $91.39 and a 200-day simple moving average of $95.98.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.